H3 antagonists (Bioprojet/Berlin Free University/INSERM/UCL)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameH3 antagonists (Bioprojet/Berlin Free University/INSERM/UCL)
Drug Alias NameFUB-130FUB-250UCL-2065FUB-132FUB-465 +[8
ClassificationSmall molecules
Mechanisms of ActionHistamine H3 receptor antagonists
TargetsHistamine H3 receptor
Therapy Area/IndicationsMental DisordersNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyUnited KingdomFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioProjet
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsMental DisordersNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A